Ajanta Pharma is primarily engaged in development, manufacturing and marketing of speciality pharmaceutical quality finished dosages.(Source : 202003-01 Annual Report Page No:70).
Financial Results:
Ajanta Pharma Ltd reported Revenues for Q4FY24 of ₹926.00 Crores up from ₹849.00 Crore year on year, a rise of 9.07%.
Total Expenses for Q4FY24 of ₹733.00 Crores down from ₹737.00 Crores year on year, a fall of 0.54%.
Consolidated Net Profit of ₹163.00 Crores up 39.32% from ₹117.00 Crores in the same quarter of the previous year.
The Earnings per Share is ₹12.92, up 41.20% from ₹9.15 in the same quarter of the previous year.
*It is important to note that the way the results have been accounted for are slightly different than the ones the companies may choose to publish.
*The presented data is automatically generated. It may occasionally generate incorrect information.